Twin Focus Capital Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,025
| Closed | -$215K | – | 168 |
|
|
2025
Q1 | $215K | Buy |
+1,025
| New | +$215K | 0.03% | 143 |
|
|
2024
Q4 | – | Sell |
-1,367
| Closed | -$270K | – | 142 |
|
|
2024
Q3 | $270K | Hold |
1,367
| – | – | 0.04% | 129 |
|
|
2024
Q2 | $234K | Sell |
1,367
-100
| -7% | -$17.2K | 0.04% | 130 |
|
|
2024
Q1 | $267K | Sell |
1,467
-486
| -25% | -$88.5K | 0.05% | 123 |
|
|
2023
Q4 | $303K | Sell |
1,953
-20
| -1% | -$3.1K | 0.06% | 120 |
|
|
2023
Q3 | $294K | Sell |
1,973
-1,216
| -38% | -$181K | 0.07% | 123 |
|
|
2023
Q2 | $430K | Sell |
3,189
-8
| -0.3% | -$1.08K | 0.09% | 123 |
|
|
2023
Q1 | $510K | Buy |
3,197
+26
| +0.8% | +$4.14K | 0.1% | 103 |
|
|
2022
Q4 | $512K | Buy |
3,171
+30
| +1% | +$4.85K | 0.11% | 100 |
|
|
2022
Q3 | $422K | Buy |
3,141
+56
| +2% | +$7.52K | 0.1% | 105 |
|
|
2022
Q2 | $472K | Buy |
3,085
+111
| +4% | +$17K | 0.11% | 101 |
|
|
2022
Q1 | $482K | Buy |
2,974
+85
| +3% | +$13.8K | 0.09% | 112 |
|
|
2021
Q4 | $391K | Buy |
2,889
+76
| +3% | +$10.3K | 0.08% | 134 |
|
|
2021
Q3 | $303K | Buy |
2,813
+484
| +21% | +$52.1K | 0.07% | 135 |
|
|
2021
Q2 | $262K | Buy |
2,329
+376
| +19% | +$42.3K | 0.06% | 154 |
|
|
2021
Q1 | $211K | Buy |
+1,953
| New | +$211K | 0.06% | 143 |
|
|
2020
Q3 | – | Sell |
-2,780
| Closed | -$273K | – | 147 |
|
|
2020
Q2 | $273K | Buy |
+2,780
| New | +$273K | 0.11% | 110 |
|